title: Dapsone-induced methemoglobinemia in leprosy patients.
authors.forename: I
authors.initials: I
authors.lastname: Kaur
authors.forename: M
authors.initials: M
authors.lastname: Mehta
authors.forename: N
authors.initials: N
authors.lastname: Agnihotri
authors.forename: S
authors.initials: S
authors.lastname: Dogra
authors.forename: N K
authors.initials: NK
authors.lastname: Ganguly
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D003579:Cytochrome Reductases / Q000378:metabolism; D042966:Cytochrome-B(5) Reductase; D003622:Dapsone / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007917:Leprostatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D007918:Leprosy / Q000188:drug therapy*; D008297:Male; D008708:Methemoglobinemia / Q000139:chemically induced* / Q000201:enzymology; D008875:Middle Aged
chemical_list: D007917:Leprostatic Agents; D003622:Dapsone; D003579:Cytochrome Reductases; D042966:Cytochrome-B(5) Reductase